Tuesday, Aug 18, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle

"vaccine"

  • Phase 3 trial of Covaxin to begin in Haryana on Nov 20

    Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.
  • Tipping point

    Developments on vaccine front offer a tentative timeline on when it could be available on a mass scale
  • Sensex, Nifty scale record high levels supported by positive vaccine news

    Tata Steel was the top gainer in the Sensex pack, rising over 4 per cent, followed by Bharti Airtel, SBI, HDFC Bank, M&M, Asian Paints and Reliance Industries.
  • New vaccine breakthrough lifts global hope against pandemic

    Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.
  • Biological E starts phase I/II trial of Covid-19 vaccine

    The vaccine candidate includes an antigen in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialisation team, along with Dynavax’s advanced adjuvant CpG 1018.
  • UK to run final stage trials of Janssen Covid vaccine

    Dr. Saul Faust, who is helping lead the study, said the research will start first in Britain but aims to recruit a total of 30,000 people in six countries around the world.
  • Russian vaccine arrives in India for human clinical trial

    The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.
  • Australian Covid-19 vaccine ready for later-stage clinical trials

    Regulatory approval was being sought for the vaccine to progress to Phase 3 clinical trials before the end of the year.
  • Serum Institute, ICMR complete enrolment in phase-III trials for COVID-19 vaccine

    SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.
  • ‘Covid-19 vaccine being developed in record time’

    Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and manufacturing capabilities of developed and developing countries. Speaking at the 28th Annual Hysea Innovation Summit, Bharat Biotech MD Dr Krishna Ella said that the pandemic vaccine coming out in 12 months […]
  • Dr Reddy’s partners with BIRAC for Sputnik V vaccine trials in India

    Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
  • Drugs Controller General of India nod for Covaxin phase 3 trials

    The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)
  • COVID-19 vaccine coming in weeks: Trump; Biden says US about to go into dark winter

    The coronavirus dominated the opening minutes of the Trump-Biden face-off with President Trump terming the contagion a “worldwide problem”.
  • Vaccine trials ‘can’t detect’ virus risk reduction: Expert

    The World Health Organisation (WHO) has identified 42 candidate vaccines in clinical trials, ten of which are in the most advanced "phase 3" stage.
  • Indonesia to provide COVID-19 vaccine to 9.1 million people at 1st phase

    The first phase of vaccination will be carried out on the groups of people with highest risk of COVID-19 infections.
  • Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine

    This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
  • Apollo Hospitals prepared to administer 10 lakh vaccine doses per day

    Whenever the Union government makes a vaccine available, the Apollo Hospitals will leverage its robust pan-India web of 19 medicine supply hubs with cold chain facilities.
  • Paris goes under curfew as Europe ramps up virus restrictions

    With over one million coronavirus deaths and nearly 40 million cases worldwide, regions like Europe that suppressed the first outbreak are again facing tough choices on how to control a new wave.
  • Covid-19 reinfection casts doubt on virus immunity: Study

    "The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine."
  • Indian-origin researchers use bovine adenovirus to develop Covid vax

    Bovine Adenovirus, also known as BAdV, is a member of the Adenoviridae family that causes disease in cattle.
« 1 … 12 13 14 15 »

Latest News

  • AP Police launch hunt for shooting academy coach after family suicide

    6 minutes ago
  • Uttam Kumar Reddy directs cautious water release for irrigation

    11 minutes ago
  • KBR Park one-way traffic system triggers confusion, snarls in Hyderabad

    11 minutes ago
  • TGSRTC revises bus routes around KBR Park amid traffic curbs

    21 minutes ago
  • Delhi HC allows JNU to continue postgraduate admissions amid deprivation points challenge

    21 minutes ago
  • Maanaveeya Development and Finance donates EVs to Hyderabad zoo

    25 minutes ago
  • Veeranari Chakali Ilamma Women’s University faces financial crisis

    31 minutes ago
  • Meta shows greater sensitivity to CSAM after Centre’s intervention: Sources

    35 minutes ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam